California based BioNano Genomics announced on Wednesday that Beijing based biochemical company Biomarker Technologies Corporation has purchased an Irys System. Biomarker picked the platform by BioNano in order to allow a more comprehensive exploration of the structural variation of genomics and to improve de novo genome assemblies meant for different animal and plant species. These include those species that bear no reference today. The Irys system relies on its high throughput IrysChip and is the perfect discovery tool for structural variation since it can detect different types of SVs in just one run. Moreover, it can also allow accurate and rapid de novo genome assembly.
Chief executive officer of Biomarker Mr Hongkun Zheng said that the company plans to join hands with BioNano in order to explore the fields of clinical research, life science, and applications service in a more in depth manner. The company is greatly impressed by the novel capabilities of the Irys system that can efficiently detect complex structural variations and largely enhance the quality of diploid genome assembly. This was featured in the Nature Method and Nature Genetics papers published over the past few weeks.
Mr Hongkun Zheng further said that the one of the goals of Biomarker Technologies is to investigate the biology that lies behind genomics. The company has been in search of a path that will enable the discovery of large and complex SVs that are not detected as easily by traditional methods such as NGS, DNA Arrays, and other platforms. The introduction of the Irys system will now allow the company to be able to deliver on the capability to witness the complexities of genomes of the population at large.
Chief scientific officer and founder of BioNano Genomics Han Cao, Ph.D., said that the Irys System allows researchers to detect structural information in a rapid and accurate manner. This can be done over long range distances with the least amount of alteration during the course of sample preparation.